Related Experiment Video
Updated: May 4, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Ensuring reliability of safety-critical clinical applications of computational cardiac models
Pras Pathmanathan1, Richard A Gray2
1Center for Devices and Radiological Health, U.S. Food and Drug Administration Silver Spring, MD, USA ; Department of Computer Science, University of Oxford Oxford, UK.
Abstract:
Computational models of cardiac electrophysiology have been used for over half a century to investigate physiological mechanisms and generate hypotheses for experimental testing, and are now starting to play a role in clinical applications. There is currently a great deal of interest in using models as diagnostic or therapeutic aids, for example using patient-specific whole-heart simulations to optimize cardiac resynchronization therapy, ablation therapy, and defibrillation. However, if models are to be used in safety-critical clinical decision making, the reliability of their predictions needs to be thoroughly investigated. In engineering and the physical sciences, the field of "verification, validation and uncertainty quantification" (VVUQ) [also known as "verification and validation" (V&V)] has been developed for rigorously evaluating the credibility of computational model predictions. In this article we first discuss why it is vital that cardiac models be developed and evaluated within a VVUQ framework, and then consider cardiac models in the context of each of the stages in VVUQ. We identify some of the major difficulties which may need to be overcome for cardiac models to be used in safely-critical clinical applications.

